{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:43:05Z","timestamp":1776912185989,"version":"3.51.2"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-026-02827-8","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:47:01Z","timestamp":1773676021000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of regional recurrences after treatment of nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Yuhao","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linghui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muling","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaodong","family":"Fei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"2827_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","DOI":"10.3322\/caac.21834"},{"key":"2827_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"Y-P Chen","year":"2019","unstructured":"Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380. https:\/\/doi.org\/10.1016\/S0140-6736(19)30956-0.","journal-title":"Lancet"},{"key":"2827_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","volume":"32","author":"P Bossi","year":"2021","unstructured":"Bossi P, Chan AT, Licitra L, Trama A, Orlandi E, Hui EP, et al. Nasopharyngeal carcinoma: ESMO-EURACAN clinical Practice guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2021;32:452\u201365. https:\/\/doi.org\/10.1016\/j.annonc.2020.12.007.","journal-title":"Ann Oncol"},{"key":"2827_CR4","doi-asserted-by":"publisher","unstructured":"Huang P-Y, Chen X-Y, Ding X, Guo L, Mo H-Y, Zou X, et al. Induction versus concurrent chemotherapy for advanced nasopharyngeal carcinoma. NEJM Evid. 2025;4:EVIDoa2400214. https:\/\/doi.org\/10.1056\/EVIDoa2400214.","DOI":"10.1056\/EVIDoa2400214"},{"key":"2827_CR5","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/cam4.5020","volume":"12","author":"X-T Xiao","year":"2023","unstructured":"Xiao X-T, Wu Y-S, Chen Y-P, Liu X, Guo R, Tang L-L, et al. Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy. Cancer Med. 2023;12:1399\u2013408. https:\/\/doi.org\/10.1002\/cam4.5020.","journal-title":"Cancer Med"},{"key":"2827_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.7150\/jca.17858","volume":"8","author":"F Xue","year":"2017","unstructured":"Xue F, Hu C, He X. Long-term patterns of regional failure for nasopharyngeal carcinoma following intensity-modulated radiation therapy. J Cancer. 2017;8:993\u201399. https:\/\/doi.org\/10.7150\/jca.17858.","journal-title":"J Cancer"},{"key":"2827_CR7","doi-asserted-by":"publisher","first-page":"693199","DOI":"10.3389\/fonc.2021.693199","volume":"11","author":"S Chen","year":"2021","unstructured":"Chen S, Yang D, Liao X, Lu Y, Yu B, Xu M, et al. Failure patterns of recurrence and metastasis after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma: results of a multicentric clinical study. Front Oncol. 2021;11:693199. https:\/\/doi.org\/10.3389\/fonc.2021.693199.","journal-title":"Front Oncol"},{"key":"2827_CR8","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.rpor.2020.04.012","volume":"25","author":"E Netto","year":"2020","unstructured":"Netto E, Ferreira M, Esteves S, Sargento I, Alexandre T, Pocinho R, et al. Improved long-term results of intensity-modulated radiotherapy for a non-endemic European nasopharyngeal carcinoma cohort: single-center retrospective study. Rep Pract Oncol Radiother. 2020;25:521\u201326. https:\/\/doi.org\/10.1016\/j.rpor.2020.04.012.","journal-title":"Rep Pract Oncol Radiother"},{"key":"2827_CR9","doi-asserted-by":"publisher","first-page":"4321","DOI":"10.3390\/cancers15174321","volume":"15","author":"MK Rooney","year":"2023","unstructured":"Rooney MK, Andring LM, Corrigan KL, Bernard V, Williamson TD, Fuller CD, et al. Hypothyroidism following radiotherapy for head and neck Cancer: a systematic review of the literature and opportunities to improve the therapeutic ratio. Cancers (Basel). 2023;15:4321. https:\/\/doi.org\/10.3390\/cancers15174321.","journal-title":"Cancers (Basel)"},{"key":"2827_CR10","doi-asserted-by":"publisher","unstructured":"Chow JCH, Cheung K-M, Cheung GTC, Tam AHP, Lui JCF, Lee FKH, et al. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: a systematic review. ctRO. Elsevier; 2022;Vol. 33. p. 83\u201392. https:\/\/doi.org\/10.1016\/j.ctro.2022.01.001.","DOI":"10.1016\/j.ctro.2022.01.001"},{"key":"2827_CR11","doi-asserted-by":"publisher","first-page":"107008","DOI":"10.1016\/j.oraloncology.2024.107008","volume":"158","author":"X Zhou","year":"2024","unstructured":"Zhou X, Shao T, Jia H, Hou L, Tang X, Yu C, et al. Current state, challenges, and future perspective of adaptive radiotherapy: a narrative review of nasopharyngeal carcinoma. Oral Oncol. 2024;158:107008. https:\/\/doi.org\/10.1016\/j.oraloncology.2024.107008.","journal-title":"Oral Oncol"},{"key":"2827_CR12","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijrobp.2009.11.024","volume":"79","author":"WT Ng","year":"2011","unstructured":"Ng WT, Lee MCH, Hung WM, Choi CW, Lee KC, Chan OSH, et al. Clinical outcomes and patterns of failure after intensity-modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2011;79:420\u201328. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.11.024.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2827_CR13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13014-023-02373-7","volume":"18","author":"X Zhou","year":"2023","unstructured":"Zhou X, Zhu J, Zhou C, Wang W, Ding W, Chen M, et al. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China. Radiat Oncol. 2023;18:190. https:\/\/doi.org\/10.1186\/s13014-023-02373-7.","journal-title":"Radiat Oncol"},{"key":"2827_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ijrobp.2025.05.019","volume":"123","author":"S-J Lin","year":"2025","unstructured":"Lin S-J, Guo Q-J, Liu Q, Ng W-T, Ahn YC, AlHussain H, et al. International consensus Guideline on delineation of the clinical target volumes at different dose levels for nasopharyngeal carcinoma (2024 version). Int J Multiling Radiat Oncol, Biol, Phys. Elsevier. 2025;123:415\u201331. https:\/\/doi.org\/10.1016\/j.ijrobp.2025.05.019.","journal-title":"Int J Multiling Radiat Oncol, Biol, Phys. Elsevier"},{"key":"2827_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S1470-2045(22)00058-4","volume":"23","author":"L-L Tang","year":"2022","unstructured":"Tang L-L, Huang C-L, Zhang N, Jiang W, Wu Y-S, Huang SH, et al. Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial. Lancet Oncol. 2022;23:479\u201390. https:\/\/doi.org\/10.1016\/S1470-2045(22)00058-4.","journal-title":"The Lancet Oncol"},{"key":"2827_CR16","doi-asserted-by":"publisher","first-page":"109860","DOI":"10.1016\/j.radonc.2023.109860","volume":"188","author":"X Ding","year":"2023","unstructured":"Ding X, Cui X, Cui X, Wang S. Efficacy and toxicities of elective upper-neck irradiation versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: a meta-analysis. Radiother Oncol. 2023;188:109860. https:\/\/doi.org\/10.1016\/j.radonc.2023.109860.","journal-title":"Radiother Oncol"},{"key":"2827_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.21037\/cco-22-95","volume":"12","author":"MLK Chua","year":"2023","unstructured":"Chua MLK, Lua JYH, Ng W-T, Lee AWM. Management of the neck in nasopharyngeal carcinoma-time for a radical change? Chin Clin Oncol. 2023;12:8. https:\/\/doi.org\/10.21037\/cco-22-95.","journal-title":"Chin Clin Oncol"},{"key":"2827_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13014-022-02028-z","volume":"17","author":"R Zhai","year":"2022","unstructured":"Zhai R, Lyu Y, Ni M, Kong F, Du C, Hu C, et al. Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy. Radiat Oncol. 2022;17:57. https:\/\/doi.org\/10.1186\/s13014-022-02028-z.","journal-title":"Radiat Oncol"},{"key":"2827_CR19","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1186\/s12885-023-11212-7","volume":"23","author":"Y Liu","year":"2023","unstructured":"Liu Y, Han Y, Liu F, Hu D, Chen Z, Wang P, et al. Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial. BMC Cancer. 2023;23:724. https:\/\/doi.org\/10.1186\/s12885-023-11212-7.","journal-title":"BMC Cancer"},{"key":"2827_CR20","doi-asserted-by":"publisher","unstructured":"Zhang J, Li M, Zhang K, Zheng A, Li G, Huang W, et al. Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: a randomized, multicenter, phase III clinical trial. cited 2025 Oct 15]; https:\/\/doi.org\/10.1002\/cac2.12601.","DOI":"10.1002\/cac2.12601"},{"key":"2827_CR21","doi-asserted-by":"publisher","unstructured":"Cursio J, Juloori A, Omenuko NJ, MacCracken E, Katipally RR, Blair EA, et al. Functional and survival outcomes in HPV positive oropharyngeal squamous cell cancer treated with response-adaptive de-escalation: a pooled analysis. In: Journal of clinical oncology [Internet]. American Society of Clinical Oncology; 2025. cited 2025 Oct 15]; https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.6068.","DOI":"10.1200\/JCO.2025.43.16_suppl.6068"},{"key":"2827_CR22","doi-asserted-by":"publisher","unstructured":"Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, et al. Reduced-dose radiation therapy for HPV-Associated oropharyngeal carcinoma (NRG Oncology HN002). J Clin Oncol. 2021;39:956\u201365. https:\/\/doi.org\/10.1200\/JCO.20.03128.","DOI":"10.1200\/JCO.20.03128"},{"key":"2827_CR23","doi-asserted-by":"publisher","unstructured":"Margalit DN, Anker CJ, Aristophanous M, Awan M, Bajaj GK, Bradfield L, et al. Radiation therapy for HPV-Positive oropharyngeal squamous cell carcinoma: an ASTRO clinical Practice Guideline. Practical Radiat Oncol. Elsevier. 2024;14:398\u2013425. https:\/\/doi.org\/10.1016\/j.prro.2024.05.007.","DOI":"10.1016\/j.prro.2024.05.007"},{"key":"2827_CR24","doi-asserted-by":"publisher","unstructured":"Nutting C, Finneran L, Roe J, Sydenham MA, Beasley M, Bhide S, et al. Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial. Lancet Oncol. 2023;24:868\u201380. https:\/\/doi.org\/10.1016\/S1470-2045(23)00265-6.","DOI":"10.1016\/S1470-2045(23)00265-6"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02827-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02827-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T02:22:16Z","timestamp":1776910936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02827-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2827"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02827-8","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Fujian Cancer Hospital (YKT2020-011\u201301) and conducted in accordance with the Declaration of Helsinki. Given the retrospective observational nature, the individual informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}